Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVI
Status:
Completed
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Clinical research includes Determination of efficacy and acceptability of the local medicine
"Rutan tablets 0,025" in children and teenagers 6-18 years old with COVID-19 and/or acute
respiratory viral infections. And also the purpose of the study was to study clinical and
laboratory changes when using Rutan in patients with Covid 19 clinical methods such as
collection of anamnesis, dynamic examination of patients, catamnestic observation - a
telephone survey, as well as biochemical, immunological, virologic PCR and ELISA tests.
Phase:
Phase 2
Details
Lead Sponsor:
Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan